Supercharge Clinical Translation by Advancing Gene Engineering, Optimizing Differentiation & Enhancing Expansion to Achieve Unrivalled Clinical Scale for the Future of Cell Therapy

December 6-7, 2022 | Boston, MA

Welcome to the 2nd iPSC-Derived Cell Therapies Summit

Showcasing Discovery, Translation, CMC and Regulatory Advances at the Flagship iPSC Summit

Continued investment into the iPSC space is accelerating development of both autologous and off-the-shelf therapies for a broad range of indications. However, translational, regulatory and scalability challenges are hindering clinical advances.

The iPSC-Derived Cell Therapies Summit is back for its second year and this time it’s bigger, better and coming to Boston! With two separate tracks of content spanning translation and discovery to CMC and regulation, this dedicated forum is your one-stop shop to learn from the industries leaders including Century Therapeutics, Sana Biotechnology and Vita Therapeutics, to solve your differentiation, expansion, quality and engineering challenges.

Unite and reconnect with the community driven to create best-in-class, safe and effective iPSC-derived therapies.

World-Class Speaker Faculty Includes:

2021 Attendees Included:

2022 Company Logos - iPSC (1880 × 800 px)

"This meeting offers an invaluable opportunity for leaders in this field to discuss the unique opportunities and challenges associated with iPSC-derived products, which I expect to dominate the field of cell-based therapies in the near future."
Chief Operating Officer, Cynata Therapeutics

Our Partners

Other Events in the Series